Trazodone in the Management of Major Depression Among Elderly Patients with Dementia: A Narrative Review and Clinical Insights

Andrea Fagiolini; Ana González‐Pinto; Kamilla Woznica Miskowiak; Pedro Morgado; Allan H. Young; Eduard Vieta

doi:10.2147/ndt.s434130

Abstract

1 min read

Trazodone may be beneficial for patients with dementia or other neurological disorders comorbid with MDD, especially when the clinical picture of depression includes or is comorbid to symptoms of insomnia, irritability, inner tension, anxiety, or psychomotor agitation.

Related publications

Article2023

Role of trazodone in treatment of major depressive disorder: an update

Andrea Fagiolini, Ana González‐Pinto, Kamilla Woznica Miskowiak, Pedro Morgado, Allan H. Young, Eduard Vieta

Article2020

Characterization of rapid cycling bipolar patients presenting with major depressive episode within the BRIDGE‐II‐MIX study

Maria Antonietta Furio, Dina Popović, Eduard Vieta, Yelena Stukalin, Michal Hagin, Carla Torrent, Jean‐Michel Azorin, Jules Angst, Charles L. Bowden, Sergey Mosolov, Allan H. Young, Giulio Perugi

Article2018

Trazodone in the Management of Major Depression Among Elderly Patients with Dementia: A Narrative Review and Clinical Insights

Abstract

Discussion(0)

Related publications

Role of trazodone in treatment of major depressive disorder: an update

Characterization of rapid cycling bipolar patients presenting with major depressive episode within the BRIDGE‐II‐MIX study

Barriers and Facilitators for Guidelines with Depression and Anxiety in Parkinson’s Disease or Dementia

Effects of Trazodone and Fluoxetine in the Treatment of Major Depression

Clinical characterisation of dual depression and association with bipolarity features